Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or locally adv ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback